Romina joined ViiV Healthcare in November 2013 as European Medical Lead for Dolutegravir. In her role, she provides European oversight for the medical and virological aspects on Dolutegravir for Europe and contributes with a specific European view related with regional unmet medical needs, as part of the Dolutegravir Global team.
Prior to joining ViiV Healthcare, she spent almost 5 years at Gilead Sciences where she was Associate Medical Director for Europe and then Medical Director for the International region. Romina practice clinical care in the HIV/ID setting since 2000. She started in Buenos Aires with Pr Pedro Cahn, then Vancouver with Pr Julio Montaner and finished her PhD in integrase resistance in Paris with Pr Francois Clavel, maintaining always her clinical practice
Romina studied Medicine at Buenos Aires University and Mayo Clinic, obtaining her diploma in 2000, and finishing her ID specialization with Pr Pedro Cahn in Buenos Aires, she earned his PhD in Virology and Molecular Biology from the Sorbonne University in Paris, in 2009, while conducting research at the ANRS in the laboratory of Pr Francois Clavel, who first sequenced HIV-2. She did an HIV/AIDS fellowship in British Columbia under the Direction of Pr Julio Montaner at the Centre of Excellence of HIV/AIDS in Vancouver and finished her training in Paris.
She is still honorary associate professor at the University of Buenos Aires, at the virology department part of the National Reference Centre for HIV/AIDS.
Now Romina is Global Director of Clinical Virology and Early Drug Development for ViiV Healthcare.